Bernard Haendler
15PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Jan 17, 2025
Inhibition of EphB4 Receptor Signaling by Ephrin-B2-Competitive and Non-Competitive DARPins Prevents Angiogenesis.Weronika Trun, Amaury Fernández-Montalván, Yong-Jiang Cao
|Jan 08, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models.Urs B Hagemann, Christoph A Schatz, Mari I Suominen
|Apr 09, 2024
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer.Christoph A Schatz, Sabine Zitzmann-Kolbe, Ingrid Moen
|Jan 23, 2024
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review.Paulina J Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
|Jan 15, 2024
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller
|Feb 11, 2023
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment.Fabio Raith, Daniel H O'Donovan, Clara Lemos
Pageof 3
Frequent Collaborators
2 joint publications
Stefanie Hammer
2 joint publications
Andreas Schlicker
2 joint publications
Sabine Zitzmann-Kolbe
2 joint publications
Jenny Karlsson
2 joint publications
Mari I Suominen
2 joint publications
Christoph A Schatz
2 joint publications
Sanna-Maria Käkönen
1 joint publications
Matias Knuuttila
1 joint publications
Dominik Mumberg
1 joint publications
Fabio Raith
